1. Name: Dr. Prabhat Singh Malik

2. Designation:  Assistant Professor of Medical Oncology

3. Affliation: Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi

4. E mail : This email address is being protected from spambots. You need JavaScript enabled to view it.

5. Date of Birth: 10^th Nov 1979
6. Educational Qualification :

Degree	College/University	Subject	Year
MBBS	S.S.Medical College, Rewa, (M.P.), India	Medical graduation	1996-2001
MD	M.G.M. Medical College, Indore, (M.P.),India	Medicine	2004-2007
DM	All India Institute of Medical Sciences, New Delhi, India.	Medical Oncology	2009- June 2012

 

7.      Teaching and Research Experience

Name of The post	Institute	Tenure    From                          To
Senior Research Associate (Pool Officer)	Dept of Medical Oncology, AIIMS, New Delhi	1/5/2013- 29-7-14	Completed
Assistant Professor	Dept of Medical Oncology, AIIMS New Delhi	30-7-14  - till date

 

8.      Research specialization (Major scientific fields of interest)

1. Lung Cancer treatment
2. Molecular profiling and targeted therapies in NSCLC
3. Cancer immunology
4. Metronomic therapies and drug repositioning 

    

   9. Ongoing Research Projects

   1. A Prospective, Randomized, Multicenter Study to Compare the Safety, Tolerability and efficacy of Bevacizumab (Zydus Cadila) with Bevacizumab (Avastin) in Non Small Cell Lung Cancer (Completed)
   2. Validation of Thymidylate Synthetase and Folate Receptor alpha expression as predictive    biomarkers for efficacy of Pemetrexed based chemotherapy in advanced non squamous NSCLC
   3. Study of efficacy and safety of neoadjuvant chemotherapy in patients with stage 2B and 3 NSCLC: A pilot study
   4. A Phase III Open label Randomized control study to compare efficacy and safety of Pemetrexed-Carboplatin versus Paclitaxel-Carboplatin as induction regimen in advanced Non-squamous Non-Small-Cell lung cancer

 

 

10.    Important recent publications (last 5 years, with titles and References),

Indexed Journals

 

1. ASCENDing the anaplastic lymphoma kinase ladder: a tale of two C-nibs. Malik PS, Singh N.J Thorac Dis. 2016 Nov;8(11):E1514-E1516.PMID 5179416

    2.      Autologous stem cell transplantation for multiple myeloma: Long-term results. Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, Patekar MB, Sahoo,RK, Malik PS, Sharma OD, Gupta R.Natl Med J India. 2016 Jul-Aug;29(4):192-199. PMID 28050994 

   3.      Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer. Malik PS, Jain D, Kumar L.Oncology. 2016;91Suppl 1:26-34. doi: 10.1159/000447578. PMID 27462979 

   4.      Study of clinicopathological features, hormone immunoexpression and loss of ATRX and DAXX expression in pancreatic neuroendocrine tumors. Yadav R, Kakkar A, Sharma A, Malik PS, Sharma MC. Scand J Gastroenterol. 2016 Aug;51(8):994-9. PMID 27162024 

5.        Evaluation of epidermal growth factor receptor mutations based on mutation specific immunohistochemistry in non-small cell lung cancer: A preliminary study. Jain D, Iqbal S, Walia R, Malik P, Cyriac S, Mathur SR, Sharma MC, Madan K, Mohan A, Bhalla A, Pathy S, Kumar L, Guleria R. Indian J Med Res. 2016 Mar;143(3):308-14. PMID 27241644 

6.      Metastatic alveolar soft part sarcoma of the lung-a morphologic pitfall on cytology and aberrant CD10 expression on histology. Nambirajan A, Jain D, Malik P, Arava S, Mathur SR. DiagnCytopathol. 2015 Dec 22. doi: 10.1002/dc.23416. [Epub ahead of print] 

7.     Lung cancer: Prevalent trends and emerging concepts. Malik PS, Raina V. Indian J Med Res. 2015 Jan;141(1):5-7. PMID: 25857489 

8.     Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch.  Malik PS, Raina V, André N. Front Oncol. 2014 Apr 10;4:76. PMID : 24782987 

9.    Underutilization of Curative Treatment among Patients with NSCLC: Experience from a Tertiary Care Centre in India. Malik PS, Malik A, Deo SVS, Mohan A, Mohanti BK, Raina V.  Asian Pac J Cancer Prev. 2014;15(6):2875-8.PMID:26761917 

10.  Clinico-pathological Profile of Lung Cancer at AIIMS: A Changing Paradigm in India.  Malik PS, Sharma MC,  Mohanti BK, Shukla NK, Deo S, Mohan A, Kumar G, Raina V.Asian Pac J Cancer Prev. 2013;14(1):489-94.PMID:23534779 

 

1. Comparison of BEAM vs LEAM regimen in autologous transplant for lymphoma at AIIMS. Sharma A, Kayal S, Iqbal S, Malik PS, Raina V. Springer Plus 2013;2:489
2. Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India.Kumar L, Malik PS, Prakash G, Prabu R, Radhakrishnan V, Katyal S, Hariprasad R.Ann Hematol. 2011 Nov;90(11):1317-28. Epub 2011 Mar 16. PMID:21409382

13. H1N1 infection in children with hematological malignancies.Malik PS, Broor S, Bakhshi S.Indian Pediatr. 2011 Dec;48(12):971-3.PMID:2225315

  14.  Renal impairment due to white-cell lysis after G-CSF and chemotherapy during pediatric autologous stem cell transplantation.Malik PS, Bakhshi S. J Pediatr Hematol Oncol. 2010 Jul;32(5):416-7.PMID: 20495480 

  15.  Further progress in the treatment of multiple myeloma?Malik PS, Kumar L. Natl Med J India. 2009 Jan-Feb;22(1):25-7.PMID: 19761157

1. Principles of Drug Treatment of Cancer. Lalit Kumar, Prabhat Singh Malik. API Textbook of Medicine, 10^th edition.
2. Developments in Oncology. Lalit Kumar, Prabhat Singh Malik, API Textbook of Medicine, 10^th edition.

Book Chapters 

Research Blog: https://www.researchgate.net/profile/Prabhat_Malik2